Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share

NIAGEN BIOSCIENCE, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share

NIAGEN BIOSCIENCE, INC. (NAGE) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.

Discontinued › Income Statement › Net Income

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2019-03-07

  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-06-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-03-31 was $0.00.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-07-01 was -$0.01.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-04-01 was $0.00.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2017 was $0.11, a 450.00% increase from fiscal 2016.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2016 was $0.02.
  • NIAGEN BIOSCIENCE, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2016 was -$0.01.
Period endIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month
2018-12-31$0.00
10-K · filed 2019-03-07
2018-09-30$0.00
10-Q · filed 2018-11-07
2018-06-30$0.00
10-Q · filed 2018-08-09
$0.00
10-Q · filed 2018-08-09
2018-03-31$0.00
10-Q · filed 2018-05-10
2017-12-30$0.11
10-K · filed 2019-03-07
2017-09-30$0.12
10-Q · filed 2018-11-07
2017-07-01-$0.01
10-Q · filed 2018-08-09
-$0.01
10-Q · filed 2018-08-09
2017-04-01$0.00
10-Q · filed 2018-05-10
2016-12-31$0.02
10-K · filed 2018-03-15
2016-01-02-$0.01
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87